At week 52, results showed that 65% of patients achieved mycologic cure. The Food and Drug Administration (FDA) has expanded the approval of Jublia® (efinaconazole; Bausch Health) topical solution to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback